LRRC51 Activators
LRRC51 can influence its phosphorylation state through various intracellular signaling pathways. Dibutyryl-cAMP and Forskolin both raise intracellular cAMP levels, which in turn activate cAMP-dependent protein kinases (PKA). Once activated, PKA can directly phosphorylate LRRC51, enhancing its activity. Similarly, Zaprinast and IBMX lead to increased cAMP by inhibiting phosphodiesterases, including PDE5 and non-selective phosphodiesterases, respectively. This elevation in cAMP levels also results in the activation of PKA, which can then act on LRRC51. Meanwhile, Rolipram specifically inhibits phosphodiesterase 4, also resulting in elevated cAMP and subsequent PKA-mediated phosphorylation of LRRC51. In contrast, PMA activates protein kinase C (PKC) and Endothelin-1 activates PKC through its G-protein-coupled receptors, both of which can phosphorylate LRRC51.
The calcium ionophores Ionomycin and A23187 increase intracellular calcium concentrations, activating calcium-dependent kinases that may phosphorylate LRRC51. Anisomycin, while primarily known as a protein synthesis inhibitor, can also activate stress-activated protein kinases like JNK, which could then phosphorylate LRRC51 as part of a cellular stress response. Calyculin A and Okadaic Acid, inhibitors of protein phosphatases 1 and 2A, respectively, prevent the dephosphorylation of proteins, leading to an accumulation of phosphorylated proteins, including LRRC51. This sustained phosphorylation state can be indicative of LRRC51 activity being maintained at higher levels than under normal conditions. The myriad of chemical activators thus engage with and modulate the phosphorylation status of LRRC51 through distinct signaling pathways, resulting in its activation within cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates cAMP-dependent protein kinases (PKA). Activation of PKA can lead to downstream signaling effects that may include the phosphorylation of LRRC51, thereby enhancing its activity as part of the cAMP signaling pathway. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium levels can activate calcium-dependent protein kinases, potentially leading to the phosphorylation and activation of LRRC51 as part of calcium signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate LRRC51 as a substrate, leading to its functional activation within the PKC signaling pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that raises intracellular calcium, thereby activating calcium-dependent protein kinases which could phosphorylate and activate LRRC51. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, leading to an increase in cAMP levels in cells. Elevated cAMP activates PKA, which may in turn phosphorylate and activate LRRC51 as part of the cAMP/PKA signaling pathway. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, causing increases in intracellular cAMP and cGMP levels. This can lead to activation of PKA and subsequent phosphorylation and activation of LRRC51. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to increased cAMP levels within the cell. The increase in cAMP can activate PKA, which may phosphorylate and thereby activate LRRC51. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can also activate stress-activated protein kinases (SAPKs), such as JNK. Activation of these kinases can lead to phosphorylation of various substrates, including potentially LRRC51, as part of stress response pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), leading to increased phosphorylation levels of proteins in the cell. This could result in the maintained phosphorylation and activation of LRRC51, as phosphatases would normally counteract kinase activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is another potent inhibitor of protein phosphatases PP1 and PP2A, similar to Calyculin A. Inhibition of these phosphatases can lead to increased phosphorylation and presumed activation of proteins like LRRC51. | ||||||